Earnings Call Transcript of the conference call held on 14th May 2026.
SHARDACROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sharda Cropchem reported its best-ever annual performance in FY26 with revenue of INR 5,268 crores (up 22% YoY), EBITDA of INR 1,040 crores (up 69% YoY), and PAT of INR 681 crores (up 124% YoY). Q4 FY26 revenue was INR 2,065 crores with strong margin expansion - gross margins improved 750 bps to 37.3% and EBITDA margins reached 24.8%. The company declared total dividend of INR 15 per share. For FY27, management guided revenue growth of 10-15% with gross margins around 35% and EBITDA margins of 18-20%. The company remains debt-free with cash reserves of INR 702 crores and holds 3,011 product registrations with 1,004 applications in pipeline. Europe showed strong 16% volume growth while NAFTA de-grew 6%.
The company delivered exceptional growth driven by margin expansion and volume growth, particularly in Europe and LATAM. The guidance for FY27 appears conservative compared to FY26 performance, with margin expectations moderated from current levels. The stock benefits from being debt-free with strong cash generation and a large registration portfolio providing competitive moat.